These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 18413330)
21. More than a decade of experience and still no consensus: controversies in iron therapy. Besarab A Clin J Am Soc Nephrol; 2006 Sep; 1 Suppl 1():S1-3. PubMed ID: 17699371 [No Abstract] [Full Text] [Related]
22. Effect of erythropoietin in a patient with severe congestive heart failure--a case report. Carić T; Derek O; Carić D Coll Antropol; 2008 Jun; 32(2):641-3. PubMed ID: 18756924 [TBL] [Abstract][Full Text] [Related]
23. Congestive heart failure-related anemia and a role for erythropoietin. Akram K; Pearlman BL Int J Cardiol; 2007 May; 117(3):296-305. PubMed ID: 16901559 [TBL] [Abstract][Full Text] [Related]
24. Anemia and chronic heart failure implications and treatment options. Anand IS J Am Coll Cardiol; 2008 Aug; 52(7):501-11. PubMed ID: 18687241 [TBL] [Abstract][Full Text] [Related]
25. Impact of haemoglobin and erythropoietin dose changes on mortality: a secondary analysis of results from a randomized anaemia management trial. Lau JH; Gangji AS; Rabbat CG; Brimble KS Nephrol Dial Transplant; 2010 Dec; 25(12):4002-9. PubMed ID: 20530806 [TBL] [Abstract][Full Text] [Related]
26. [Principles of iron therapy in hemodialysis patients]. Basić-Jukić N; Kes P; Jurić I Acta Med Croatica; 2006 Dec; 60(5):457-62. PubMed ID: 17217102 [TBL] [Abstract][Full Text] [Related]
27. The cardio renal anemia syndrome: correcting anemia in patients with resistant congestive heart failure can improve both cardiac and renal function and reduce hospitalizations. Silverberg DS; Wexler D; Blum M; Iaina A Clin Nephrol; 2003 Jul; 60 Suppl 1():S93-102. PubMed ID: 12940539 [TBL] [Abstract][Full Text] [Related]
28. Impact of inflammation on nutrition, iron status, and erythropoietin responsiveness in ESRD patients. Bistrian BR; Carey LA Nephrol Nurs J; 2000 Dec; 27(6):616-22. PubMed ID: 16649343 [TBL] [Abstract][Full Text] [Related]
29. [Diagnosis and treatment of anemia in heart failure patients]. Santilli G; Tarantini L; Baio P; Senni M G Ital Cardiol (Rome); 2011 May; 12(5):319-26. PubMed ID: 21593950 [TBL] [Abstract][Full Text] [Related]
30. Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency. Usmanov RI; Zueva EB; Silverberg DS; Shaked M J Nephrol; 2008; 21(2):236-42. PubMed ID: 18446719 [TBL] [Abstract][Full Text] [Related]
31. Use of erythropoietin in heart failure management. Caiola K; Cheng JW Ann Pharmacother; 2004 Dec; 38(12):2145-9. PubMed ID: 15494385 [TBL] [Abstract][Full Text] [Related]
32. Outcomes associated with anemia in patients with heart failure. Salisbury AC; Kosiborod M Heart Fail Clin; 2010 Jul; 6(3):359-72. PubMed ID: 20630410 [TBL] [Abstract][Full Text] [Related]
33. Anemia, chronic renal disease and congestive heart failure--the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists. Silverberg DS; Wexler D; Iaina A; Steinbruch S; Wollman Y; Schwartz D Int Urol Nephrol; 2006; 38(2):295-310. PubMed ID: 16868702 [TBL] [Abstract][Full Text] [Related]
34. The hidden woes of anemia and sleep-disordered breathing in heart failure: killing two birds with one stone. Young JB Am Heart J; 2007 Nov; 154(5):805-7. PubMed ID: 17967582 [No Abstract] [Full Text] [Related]
35. Upper limit of serum ferritin: misinterpretation of the 2006 KDOQI anemia guidelines. Fishbane S Semin Dial; 2008; 21(3):217-20. PubMed ID: 18248518 [TBL] [Abstract][Full Text] [Related]
36. [The cardiorenal syndrome and erythropoietin]. Kes P; Basić-Jukić N; Jurić I; Basić-Kes V Acta Med Croatica; 2008; 62 Suppl 1():21-31. PubMed ID: 18578329 [TBL] [Abstract][Full Text] [Related]
37. Mediators of anemia in chronic heart failure. Le Jemtel TH; Arain S Heart Fail Clin; 2010 Jul; 6(3):289-93. PubMed ID: 20630403 [TBL] [Abstract][Full Text] [Related]
38. Updating practices in an evolving IV iron and anemia environment: practical solutions. Amerling R; Easom A; Juergensen P Nephrol Nurs J; 2007; 34(5):533-41; quiz 542-3. PubMed ID: 18041456 [TBL] [Abstract][Full Text] [Related]
39. Determinants of red cell distribution width (RDW) in cardiorenal patients: RDW is not related to erythropoietin resistance. Emans ME; van der Putten K; van Rooijen KL; Kraaijenhagen RJ; Swinkels D; van Solinge WW; Cramer MJ; Doevendans PA; Braam B; Gaillard CA J Card Fail; 2011 Aug; 17(8):626-33. PubMed ID: 21807323 [TBL] [Abstract][Full Text] [Related]
40. Hyporesponsiveness to erythropoiesis stimulating agents in chronic kidney disease: the many faces of inflammation. Adamson JW Adv Chronic Kidney Dis; 2009 Mar; 16(2):76-82. PubMed ID: 19233066 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]